We have detected that you are using some form of ad-blocking or filtering.
Please consider white-listing Labnodes since 1) ad-blockers like uBlock break Labnodes functionality and 2) Labnodes does not serve ads.
, a bio/informatics shared resource is still "open for business" - Visit the CDS website
Project Leader: Agnes B. Fogo, M.D.
Co-Investigator: Li-Jun Ma, M.D., Ph.D.
Consultant: Leslie Gewin, M.D.
Kidney scarring causes loss of kidney function. New insights into approaches to decrease scarring are needed, as current approaches do not stop ongoing scarring and end stage kidney disease. We have found that thymosin β4 decreases scarring in late stages of injury. We will now determine the specific cells and mechanisms, and potential for reversal of scarring with treatment with thymosin β4.
© 2010-2020. All Rights Reserved to Vanderbilt University. Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Released February 29, 2020